Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
Clinical trial NCT02849080 · COMPLETED
Trial details
- NCT number
- NCT02849080
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2018-02-28
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.